Correlation Between Acumen Pharmaceuticals and Cns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Cns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Cns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Cns Pharmaceuticals, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Cns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Cns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Cns Pharmaceuticals.
Diversification Opportunities for Acumen Pharmaceuticals and Cns Pharmaceuticals
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Acumen and Cns is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Cns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cns Pharmaceuticals and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Cns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cns Pharmaceuticals has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Cns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Cns Pharmaceuticals
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to generate 0.75 times more return on investment than Cns Pharmaceuticals. However, Acumen Pharmaceuticals is 1.34 times less risky than Cns Pharmaceuticals. It trades about -0.07 of its potential returns per unit of risk. Cns Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest 269.00 in Acumen Pharmaceuticals on August 24, 2024 and sell it today you would lose (32.00) from holding Acumen Pharmaceuticals or give up 11.9% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acumen Pharmaceuticals vs. Cns Pharmaceuticals
Performance |
| Timeline |
| Acumen Pharmaceuticals |
| Cns Pharmaceuticals |
Acumen Pharmaceuticals and Cns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acumen Pharmaceuticals and Cns Pharmaceuticals
The main advantage of trading using opposite Acumen Pharmaceuticals and Cns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Cns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will offset losses from the drop in Cns Pharmaceuticals' long position.| Acumen Pharmaceuticals vs. Terns Pharmaceuticals | Acumen Pharmaceuticals vs. X4 Pharmaceuticals | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Hookipa Pharma |
| Cns Pharmaceuticals vs. ZyVersa Therapeutics | Cns Pharmaceuticals vs. Immix Biopharma | Cns Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Cns Pharmaceuticals vs. Ocean Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |